J. Lisztwan

发表

The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-MDM2 interaction.

P. Furet, A. de Pover, P. Chène, 2012, Bioorganic & Medicinal Chemistry Letters.

Association of human CUL‐1 and ubiquitin‐conjugating enzyme CDC34 with the F‐box protein p45SKP2: evidence for evolutionary conservation in the subunit composition of the CDC34–SCF pathway

M. Gstaiger, W. Krek, H. Sutterlüty, 1998, The EMBO journal.

Priming-Dependent Phosphorylation and Regulation of the Tumor Suppressor pVHL by Glycogen Synthase Kinase 3

Claudio R. Thoma, Wilhelm Krek, Joanna Lisztwan, 2006, Molecular and Cellular Biology.

Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL

H. Moch, E. Oakeley, W. Krek, 2003, Nature.

Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction.

P. Furet, G. Bold, A. de Pover, 2014, Bioorganic & medicinal chemistry letters.

Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis

David M. Thomas, J. Desai, J. Monahan, 2010, Clinical Cancer Research.

The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer

Bin Chen, Shiuan Chen, J. Lisztwan, 2008, Breast Cancer Research.

Comprehensive Mapping of p 53 Pathway Alterations Reveals an Apparent Role for Both SNP 309 and MDM 2 Amplification in Sarcomagenesis

David M. Thomas, J. Desai, J. Monahan, 2010 .

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity.

M. Gstaiger, W. Krek, C. Wirbelauer, 1999, Genes & development.

Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL

W. Krek, A. Hergovich, J. Lisztwan, 2003, Nature Cell Biology.

Structural definitions of Jumonji family demethylase selectivity.

J. Lisztwan, E. S. Pilka, Tim James, 2015, Drug discovery today.

Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes*

M. Geiser, P. Furet, A. Goepfert, 2009, Journal of Biological Chemistry.

Knowledge-based virtual screening: application to the MDM4/p53 protein-protein interaction.

Nathan Brown, Edgar Jacoby, Caroline Engeloch, 2009, Methods in molecular biology.

Abstract 3970: Targeting the adenosine immunosuppressive pathway for cancer immunotherapy with small molecule agents

A. Hopkins, A. Schreyer, M. Whittaker, 2017 .

The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer

Bin Chen, Shiuan Chen, J. Lisztwan, 2008, Breast Cancer Research.

The central valine concept provides an entry in a new class of non peptide inhibitors of the p53-MDM2 interaction.

P. Furet, A. de Pover, P. Chène, 2012, Bioorganic & medicinal chemistry letters.